Item

ITEM ACTIONS

This item is discarded!DetailsSummary

Discarded

Journal Article

ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

MPS-Authors

/persons/resource/persons138194

Carrillo-Roa, T.
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80272

Binder, E.
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Athreya, A. P., Neavin, D., Carrillo-Roa, T., Frye, M. A., Skime, M., Rush, A., et al. (2019). ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. CLINICAL PHARMACOLOGY & THERAPEUTICS, 105, S24-S24.

Abstract

There is no abstract available